Prediction of metabolic dysfunction-associated steatotic liver disease among patients with type 2 diabetes mellitus using liver fat indices in a resource-limited clinical setting
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-alcoholic fatty liver disease (NAFLD), is the hepatic presentation of metabolic syndrome. It shares the common pathophysiology of insulin resistance with type 2 diabetic mellitus (T2DM). The aim of this study was to establish th...